Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $125.06 billion. The enterprise value is $144.79 billion.
| Market Cap | 125.06B |
| Enterprise Value | 144.79B |
Important Dates
The next estimated earnings date is Tuesday, November 18, 2025, before market open.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | Sep 26, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -2.52% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -2.52% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.60% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 26.93 and the forward PE ratio is 17.01. Medtronic's PEG ratio is 2.81.
| PE Ratio | 26.93 |
| Forward PE | 17.01 |
| PS Ratio | 3.58 |
| Forward PS | 3.38 |
| PB Ratio | 2.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.44 |
| P/OCF Ratio | 17.40 |
| PEG Ratio | 2.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.33, with an EV/FCF ratio of 27.30.
| EV / Earnings | 31.07 |
| EV / Sales | 4.23 |
| EV / EBITDA | 15.33 |
| EV / EBIT | 21.92 |
| EV / FCF | 27.30 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.01 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.94 |
| Debt / FCF | 5.39 |
| Interest Coverage | 8.95 |
Financial Efficiency
Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 5.40%.
| Return on Equity (ROE) | 9.74% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 5.40% |
| Return on Capital Employed (ROCE) | 8.31% |
| Revenue Per Employee | $360,000 |
| Profits Per Employee | $49,053 |
| Employee Count | 95,000 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, Medtronic has paid $971.00 million in taxes.
| Income Tax | 971.00M |
| Effective Tax Rate | 17.15% |
Stock Price Statistics
The stock price has increased by +9.13% in the last 52 weeks. The beta is 0.79, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +9.13% |
| 50-Day Moving Average | 92.95 |
| 200-Day Moving Average | 88.43 |
| Relative Strength Index (RSI) | 64.77 |
| Average Volume (20 Days) | 7,598,419 |
Short Selling Information
The latest short interest is 12.79 million, so 1.00% of the outstanding shares have been sold short.
| Short Interest | 12.79M |
| Short Previous Month | 14.09M |
| Short % of Shares Out | 1.00% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, Medtronic had revenue of $34.20 billion and earned $4.66 billion in profits. Earnings per share was $3.62.
| Revenue | 34.20B |
| Gross Profit | 22.36B |
| Operating Income | 6.61B |
| Pretax Income | 5.66B |
| Net Income | 4.66B |
| EBITDA | 9.45B |
| EBIT | 6.61B |
| Earnings Per Share (EPS) | $3.62 |
Balance Sheet
The company has $8.12 billion in cash and $28.61 billion in debt, giving a net cash position of -$20.47 billion or -$15.96 per share.
| Cash & Cash Equivalents | 8.12B |
| Total Debt | 28.61B |
| Net Cash | -20.47B |
| Net Cash Per Share | -$15.96 |
| Equity (Book Value) | 48.13B |
| Book Value Per Share | 37.36 |
| Working Capital | 11.69B |
Cash Flow
In the last 12 months, operating cash flow was $7.15 billion and capital expenditures -$1.84 billion, giving a free cash flow of $5.30 billion.
| Operating Cash Flow | 7.15B |
| Capital Expenditures | -1.84B |
| Free Cash Flow | 5.30B |
| FCF Per Share | $4.13 |
Margins
Gross margin is 65.38%, with operating and profit margins of 19.31% and 13.63%.
| Gross Margin | 65.38% |
| Operating Margin | 19.31% |
| Pretax Margin | 16.55% |
| Profit Margin | 13.63% |
| EBITDA Margin | 27.62% |
| EBIT Margin | 19.31% |
| FCF Margin | 15.51% |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 2.91%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 2.91% |
| Dividend Growth (YoY) | 1.44% |
| Years of Dividend Growth | 49 |
| Payout Ratio | 77.88% |
| Buyback Yield | 2.52% |
| Shareholder Yield | 5.45% |
| Earnings Yield | 3.75% |
| FCF Yield | 4.27% |
Analyst Forecast
The average price target for Medtronic is $102.62, which is 5.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $102.62 |
| Price Target Difference | 5.25% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 5.55% |
| EPS Growth Forecast (5Y) | 15.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.82 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 6 |